Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
0.055 USD | -15.84% | 0.00% | -43.30% |
2023 | Remedent, Inc. Reports Earnings Results for the Full Year Ended March 31, 2023 | CI |
2022 | Remedent, Inc. Reports Earnings Results for the Full Year Ended March 31, 2022 | CI |
Sales 2022 | 402K 32.06M | Sales 2023 | 46.11K 3.68M | Capitalization | 3.07M 245M |
---|---|---|---|---|---|
Net income 2022 | - 0 | Net income 2023 | - 0 | EV / Sales 2022 | 7.44 x |
Net cash position 2022 | 2.52K 201K | Net cash position 2023 | 27.69K 2.21M | EV / Sales 2023 | 65.9 x |
P/E ratio 2022 * |
-
| P/E ratio 2023 |
-
| Employees | 3 |
Yield 2022 * |
-
| Yield 2023 |
-
| Free-Float | 61.46% |
1 day | -15.84% | ||
Current month | -25.68% | ||
1 month | -25.68% | ||
3 months | -15.38% | ||
6 months | -63.33% | ||
Current year | -43.30% |
Managers | Title | Age | Since |
---|---|---|---|
Guy de Vreese
CEO | Chief Executive Officer | 69 | 31/03/02 |
Director of Finance/CFO | 59 | 29/03/05 |
Members of the board | Title | Age | Since |
---|---|---|---|
Fred Kolsteeg
BRD | Director/Board Member | 81 | 31/03/02 |
Guy de Vreese
CEO | Chief Executive Officer | 69 | 31/03/02 |
Director of Finance/CFO | 59 | 29/03/05 |
1st Jan change | Capi. | |
---|---|---|
-43.30% | 1.06M | |
-2.09% | 187B | |
-2.37% | 106B | |
-4.11% | 66.9B | |
+1.89% | 49.45B | |
+16.82% | 48B | |
+4.06% | 40.84B | |
+2.77% | 26.48B | |
+1.61% | 26.25B | |
+12.96% | 24.62B |
- Stock Market
- Equities
- REMI Stock